Latest filing published 21 Dec 2021 for Epigral Limited, €78k.
Ashishbhai Natawarlal Soparkar discloses dealings in Epigral Limited to SEBI (PIT + SAST). Over a trading history stretching from 1 December 2021 to 21 December 2021, the count stands at 4 filings.
The open-market record is one-sided, with 4 purchases worth €211k and not one sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
The median purchase comes to €48k. Clusters matter here: 4 out of 4 purchases overlapped with buying by a colleague within 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.
The newest entry dates from 21 December 2021: an open-market purchase of €78k, in Epigral Limited. Most trades are made public on the day they happen. That lag is the time during which only the insider knows about the trade. This summary is built from SEBI (PIT + SAST) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations